Join faculty Dr. Jim Bussel and Dr. Andra James for our next FWGBD webinar, Case-Based Conversation on FNAIT: Fetal and Neonatal Thrombocytopenia on Wednesday, May 12, 2021, from 12:00-1:00 pm ET.
Dr. Jim Bussel commented on the rare incidence of patients who received the COVID-19 vaccine and developed ITP in a recent New York Times article to help providers identify the best therapies for treatment and improve patient care.
Dr. Lisa Baumann Kreuziger, MD, MS, Medical Director at the Versiti Blood Center of Wisconsin, was praised by White House advisor and director of the National Institute of Allergy and Infectious Diseases, Dr. Anthony Fauci, for her leadership on a national COVID-19 panel that recommends the best treatment options for people with the virus.
On Thursday, February 25, 2021, from 2:00-3:00 PM EST, the CDC will be hosting a webinar on the new clinical practice guidelines for the diagnosis and management of von Willebrand Disease (VWD), developed in concert by ASH, ISTH, NHF, WFH, and UKMC.
FWGBD Research Award: Promoting XXcellence in Women’s Health: Optimal Management of Women and Girls with Blood Disorders 1) FWGBD Special Research Grant Award 2020*Focus Area: …
ASH, ISTH, NHF, WFH, and UKMC have developed new clinical practice guidelines for the diagnosis and management of von Willebrand Disease (VWD), accompanied by clinical tools and resources to help providers implement the recommendations.
FWGBD is hosting its biennial colloquium on uterine hemostatic disorders on Tuesday, March 9, 2021, from 9:00 am - 12:30 pm ET. Registration is now open!
The CDC is hosting a Public Health Webinar Series on Blood Disorders. Its next webinar will discuss the WFH Treatment Guidelines, and will be held Thursday, December 10, from 2:00-3:00 pm ET.
Researchers at Michigan State University have identified a potential genetic target for treating a severe, more painful form of endometriosis. The researchers have found a link to a mutat…